Development and validation of prediction model for pre‐eclampsia‐related maternal adverse outcome: retrospective cohort study

Documenti analoghi

• EP17.27: Prognostic value of maternal N‐terminal pro‐B‐type natriuretic peptide for prediction of adverse maternal outcomes in women with pre‐eclampsia
  di: P. Palmrich, et al.
  Pubblicazione: (2024)
• OP13.05: Assessment of the angiogenic ratio versus glycosylated fibronectin in predicting adverse maternal outcome in women with suspected pre‐eclampsia
  di: Y. Wah, et al.
  Pubblicazione: (2024)
• Effect of aspirin on maternal hemodynamics in Chinese women at high risk for preterm pre‐eclampsia: longitudinal study
  di: X. Wang, et al.
  Pubblicazione: (2025)
• Angiogenic factors and fetal Doppler for predicting adverse pregnancy outcome in early‐onset small fetuses with and without pre‐eclampsia
  di: E. Bonacina, et al.
  Pubblicazione: (2026)
• Externally validated prediction models for pre‐eclampsia: systematic review and meta‐analysis
  di: S. A. Tiruneh, et al.
  Pubblicazione: (2024)